GET DAILY SIGNALSIMAX Delivers Record Quarter with +64% Revenue Growth
Key Takeaways
- IMAX delivered the strongest quarterly financial results in company history, with revenue of $174.6 million, up 64% year over year.
- Adjusted earnings per share (EPS) reached $2.21, compared with $0.47 a year earlier, and more than doubled the analyst consensus estimate.
- Record global box office of $712 million was driven by Christopher Nolan's "The Odyssey," which generated more than $550 million in IMAX box office.
- Adjusted EBITDA climbed to $121 million, a record margin of 69%.
- Management said it expects to significantly exceed its prior 2026 global box office guidance of $1.4 billion.
Earnings Context and Why It Matters
IMAX's third quarter stands out as a clear demonstration of the premium large-format cinema model's strength. The results were powered by "The Odyssey," which set a new record as the highest-grossing IMAX release ever and showed how a major blockbuster can translate efficiently through the company's licensing and revenue-sharing setup. For investors, the report highlights the operating leverage in the business: with a network of roughly 1,800 commercial systems in place, additional box office flows to the bottom line at very high margins. The quarter also provides insight into network growth, with system signings picking up ahead of an expected strong slate of releases.
Reported Results
IMAX reported third-quarter 2026 revenue of $174.6 million, a 64% increase from $106.7 million in the prior-year period and ahead of consensus estimates of roughly $168.5 million. Net income reached $117.1 million, up 418% from $22.6 million a year earlier, while diluted earnings per share on a GAAP basis came in at $1.96, compared with $0.37 in the year-ago quarter.
Adjusted EPS of $2.21 rose sharply from $0.47 a year ago and comfortably exceeded analyst expectations of around $1.06. The adjusted figure includes a one-time benefit of roughly $0.63 per share from the release of a deferred tax valuation allowance; excluding that item, adjusted EPS was approximately $1.58, still well above consensus. Adjusted EBITDA reached $121 million, up from $51.8 million, producing a record margin of 69%. I also checked this using Tickeron's AI Screener to compare the results against peers in the sector.
Content Solutions revenue more than doubled to $94.0 million, while Technology Products and Services revenue rose 28% to $77.3 million. Global box office hit a record $712 million, nearly double the previous quarterly record of $372 million.
Market Reaction and Investor Sentiment
Heading into the report, sentiment around IMAX had been building on the strength of "The Odyssey" and record monthly box office results. The outsized earnings beat reinforced confidence in the company's operating leverage, though shares reflected some near-term volatility as investors weighed the impact of a tough year-over-year comparison in 2027. From what I see, key risk factors include the one-time nature of the tax valuation allowance release and the concentration of box office performance in a single title. Still, the combination of record margins, accelerating system signings, and raised full-year guidance signals that the underlying business momentum extends beyond any single film.
Forward Outlook and Key Factors to Monitor
Management's commentary pointed to a strong finish to 2026, with expectations to significantly exceed the prior full-year global box office guidance of $1.4 billion and to deliver an adjusted EBITDA margin meaningfully above the mid-40s range previously guided. Investors will be watching whether fourth-quarter releases sustain that momentum.
A central catalyst is "Dune: Part Three," scheduled for December. Management noted more than $30 million in pre-sales through its first month, already ranking as the company's second-highest pre-sales of all time. This also highlights a broader theme management emphasized: dynamic ticket pricing and the case for exhibition partners to add more IMAX auditoriums.
Network expansion remains a key indicator. IMAX reported 105 system signings year-to-date, with about 65% at new locations, and a pipeline of potential agreements for roughly 150 new and upgraded locations worldwide. Investors should monitor the conversion of that pipeline into installations.
Finally, watch for developments in cost discipline, margin flow-through, and capital allocation, including the share repurchase program, which had about $237 million remaining under its authorization as of September 30, 2026. I ran a quick scan with Tickeron's AI Screener to see how IMAX stacks up on valuation metrics relative to the broader entertainment group.
Exploring AI Tools in My Research
I frequently use Tickeron's AI Screener when evaluating earnings reports like this one. It allows me to quickly filter stocks by fundamentals, technical patterns, and performance metrics, helping me spot comparable opportunities across industries without spending hours on manual analysis. This tool has become a regular part of how I cross-check ideas and refine my watchlist.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
IMAX in upward trend: price may jump up because it broke its lower Bollinger Band on November 05, 2026
IMAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 35 of 40 cases where IMAX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMAX advanced for three days, in 221 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 151 of 231 cases where IMAX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IMAX as a result. In 55 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.
The Moving Average Convergence Divergence Histogram (MACD) for IMAX turned negative on October 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 29 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
IMAX moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IMAX crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMAX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 9 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. IMAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.417) is normal, around the industry mean (13.151). P/E Ratio (63.329) is within average values for comparable stocks, (39.472). Projected Growth (PEG Ratio) (0.934) is also within normal values, averaging (2.376). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (7.037) is also within normal values, averaging (2.932).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of projection and sound systems for large screen theaters
Industry MoviesEntertainment
Advertisement